Lucía Martín-Banderas

4PUBLICATIONS
13CO-AUTHORS
Biologically active moleculesGlycoconjugatesCancer therapy (excl. chemotherapy and radiation therapy)Cheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 04, 2026
Targeted delivery of the CB2 receptor agonist JWH-133 via VCAM-1-functionalised nanoparticles attenuates atherosclerosis and reveals sex-specific therapeutic outcomes.

|Apr 25, 2025
Enhanced Metabolic Syndrome Management Through Cannabidiol-Loaded PLGA Nanoparticles: Development and In Vitro Evaluation.

Mazen M El-Hammadi, Lucía Martín-Navarro, Esther Berrocoso

|Jan 16, 2023
Evaluation of poly (lactic-co-glycolic acid) nanoparticles to improve the therapeutic efficacy of paclitaxel in breast cancer.

Laura Cabeza, Mazen M El-Hammadi, Raul Ortiz

|May 05, 2022
Cannabinoids as Emergent Therapy Against COVID-19.

Joseph McGrail, Lucía Martín-Banderas, Matilde Durán-Lobato

Pageof 1

Frequent Collaborators

2 joint publications

Mazen M El-Hammadi

1 joint publications

Joseph McGrail

1 joint publications

Matilde Durán-Lobato

1 joint publications

Laura Cabeza